Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biolife Solutions (BLFS)

Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biolife Solutions 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021 USA

www.biolifesolutions.com Employees: 155 P: 425-402-1400 F: 425-402-1433

Sector:

Medical

Description:

BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today.

Key Statistics

Overview:

Market Capitalization, $K 897,897
Enterprise Value, $K 869,857
Shares Outstanding, K 48,300
Float, K 47,237
% Float 97.80%
Short Interest, K 2,997
Short Float 6.20%
Days to Cover 7.69
Short Volume Ratio 0.81
% of Insider Shareholders 2.20%
% of Institutional Shareholders 93.24%

Financials:

Annual Sales, $ 96,210 K
Annual Net Income, $ -4,600 K
Last Quarter Sales, $ 18,790 K
Last Quarter Net Income, $ 11,070 K
EBIT, $ -16,350 K
EBITDA, $ -11,660 K

Growth:

1-Year Return -28.96%
3-Year Return -14.53%
5-Year Return -49.33%
5-Year Revenue Growth 100.06%
5-Year Earnings Growth 1,200.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.04 on 02/26/26
Next Earnings Date 05/14/26
Earnings Per Share ttm 0.12
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 500.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-14 on 01/29/14

BLFS Ratios

Ratio
Price/Earnings ttm 163.75
Price/Earnings forward 173.38
Price/Earnings to Growth N/A
Return-on-Equity % 1.71%
Return-on-Assets % 1.54%
Profit Margin % -4.78%
Debt/Equity 0.01
Price/Sales 9.86
Price/Cash Flow 85.82
Price/Book 2.54
Book Value/Share 7.72
Interest Coverage -0.78
60-Month Beta 1.90
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.